报价延迟最少15分钟:2026/02/12 08:11 EST
盘前时段
|
||||
|
95.74 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
7.42/14.80
|
|
企业价值
14.57B
|
| 资产负债 |
|
每股账面净值
122.25
|
| 现金流量 |
|
现金流量率
0.10
|
| 损益表 |
|
收益
1.76B
|
|
每股收益
104.98
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. |
